Lakeside Holding Limited filings document the regulatory record of a Nasdaq-listed emerging growth company with common stock registered under symbol LSH. The company’s disclosures cover its cross-border logistics and pharmaceutical distribution operations, material events reported on Form 8-K, late-filing notices for quarterly reports, and governance matters submitted to stockholder votes.
Proxy materials describe director elections, amendments to charter and bylaw provisions, authorized common and preferred stock proposals, share-issuance approvals, quorum and voting-threshold matters, and other capital-structure governance items. The filing record also includes Nasdaq continued-listing notices, board changes, annual and special meeting results, and related disclosure controls for a public operating company.
Lakeside Holding Limited filed an amendment to its current report to correct the disclosed terms of a private placement. The amendment restates Item 1.01 and Item 9.01 to show that the aggregate number of shares issued was 2,000,000 (previously reported as 1,500,000) and that the purchase price per share was $0.75 (previously reported as $1.00). The amendment references an Amended Securities Purchase Agreement filed as Exhibit 10.1 (dated August 5, 2025).
Other than these corrections, the Original report filed on July 22, 2025 remains unchanged. The amendment is signed by CFO Long Yi on August 11, 2025. The filing identifies the company as a Nasdaq-listed registrant under the ticker LSH and indicates it is an emerging growth company.
Lakeside Holding Limited entered into a Securities Purchase Agreement to issue an aggregate of 1,807,229 shares of common stock at $0.83 per share, producing gross proceeds of approximately $1,500,000.07. The agreement contains customary representations, warranties and covenants, and the company intends to use the net proceeds for general corporate purposes.
The offering was completed as a private placement relying on exemptions under Section 4(a)(2) and/or Regulation S of the Securities Act; the shares are unregistered and may not be offered or sold in the United States absent registration or an applicable exemption. The form of the Securities Purchase Agreement is filed as Exhibit 10.1.
Lakeside Holding (Nasdaq: LSH) filed a Form 8-K disclosing that on June 24 2025 it executed a Securities Purchase Agreement with several investors for a private placement of 3,000,000 common shares at $1.00 per share, generating approximately $3.0 million in gross proceeds.
The shares are being issued under the Section 4(a)(2)/Regulation S exemptions and therefore are unregistered securities subject to transfer restrictions. Proceeds are earmarked for general corporate purposes. The agreement contains customary representations, warranties and covenants and is included as Exhibit 10.1.
The filing also triggers Item 3.02 disclosure for unregistered sales of equity securities. No additional financial statements, pro-formas, or risk factors were provided, and no other material events were reported.